Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.

Hutchinson M, Fox RJ, Miller DH, Phillips TJ, Kita M, Havrdova E, O'Gorman J, Zhang R, Novas M, Viglietta V, et al.

J Neurol. 2013 Jun 8. PMID: 23749293. Abstract